STOCK TITAN

Dynatronics Corp SEC Filings

DYNT OTC

Welcome to our dedicated page for Dynatronics SEC filings (Ticker: DYNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Wondering where Dynatronics hides details about new rehabilitation devices, cash-flow trends, or FDA risk factors? Most investors start with the 200-plus pages of a 10-K, only to spend hours hunting for segment revenue tied to treatment tables or athletic-training supplies. This page gathers every Dynatronics SEC filing in one place, so you can move straight to the numbers that matter.

Use Stock Titan’s AI-powered summaries to turn dense disclosures into clear takeaways. Whether you need the latest Dynatronics quarterly earnings report 10-Q filing or a surprise 8-K material events explained, our engine highlights revenue shifts, supply-chain updates, and regulatory notes within seconds. Real-time alerts flag each new Dynatronics Form 4 insider transactions real-time, letting you track when executives buy or sell shares.

  • Dynatronics insider trading Form 4 transactions – monitor director and officer moves.
  • Dynatronics annual report 10-K simplified – see product-line profitability, FDA discussions, and risk factors distilled.
  • Dynatronics proxy statement executive compensation – quickly compare pay packages to peer med-tech firms.
  • Dynatronics earnings report filing analysis – evaluate quarter-over-quarter momentum.

Every filing—10-K, 10-Q, 8-K, S-1, and more—appears within minutes of hitting EDGAR. Our expert annotations answer real queries like “Dynatronics SEC filings explained simply” and “understanding Dynatronics SEC documents with AI,” saving you hours of manual review. When material disclosures drop, you already know where to look.

Rhea-AI Summary

Dynatronics Corp. (DYNT) – Insider Form 4 filing dated 07/02/2025 details an equity transaction by long-time director and >10% shareholder Stuart M. Essig.

Nature of the transaction: Code “J” indicates a non-open-market event. The company paid the quarterly dividend on its 8% Preferred Stock in the form of DYNT common shares, valued at 90% of the 10-day average closing bid price. At a referenced value of $0.0655 per share, Mr. Essig received the stock rather than cash.

Shares received:

  • Direct account: 870,203 new common shares
  • Family trust (indirect): 174,652 new common shares
  • Total acquired: 1,044,855 shares

Post-transaction holdings: Essig now directly owns 3,559,764 DYNT shares and indirectly owns 695,616 shares through a family trust.

The acquisition arises from a routine dividend payment rather than an elective open-market purchase, yet it still increases insider ownership and may align interests with common shareholders. No derivative securities were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Dynatronics Corp. (DYNT) – Insider Form 4 filing dated 07/02/2025 details an equity transaction by long-time director and >10% shareholder Stuart M. Essig.

Nature of the transaction: Code “J” indicates a non-open-market event. The company paid the quarterly dividend on its 8% Preferred Stock in the form of DYNT common shares, valued at 90% of the 10-day average closing bid price. At a referenced value of $0.0655 per share, Mr. Essig received the stock rather than cash.

Shares received:

  • Direct account: 870,203 new common shares
  • Family trust (indirect): 174,652 new common shares
  • Total acquired: 1,044,855 shares

Post-transaction holdings: Essig now directly owns 3,559,764 DYNT shares and indirectly owns 695,616 shares through a family trust.

The acquisition arises from a routine dividend payment rather than an elective open-market purchase, yet it still increases insider ownership and may align interests with common shareholders. No derivative securities were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Form 4 filed on 07/02/2025 shows that Provco Ventures 1 LP, a 10% beneficial owner of Dynatronics Corp. (DYNT), received 522,122 shares of common stock on 07/01/2025. The transaction is coded “J,” indicating a non-open-market acquisition tied to a contractual arrangement. The footnote clarifies that the shares represent payment of the 8% preferred-stock quarterly dividend, valued at $0.0655 per share (90% of the 10-day average closing bid price). After the issuance, Provco’s direct holdings rose to 2,155,561 shares, implying a step-up of roughly 32% from the prior 1,633,439 share position. Because the dividend was paid in equity rather than cash, the transaction increases the public float and introduces incremental dilution for existing common shareholders, although the exact percentage of dilution cannot be calculated from the filing alone.

No derivative securities were reported in Table II, and there were no sales or option exercises disclosed. The filing is made by a single reporting person and does not amend a prior Form 4.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Dynatronics (DYNT)?

The current stock price of Dynatronics (DYNT) is $0.088 as of July 14, 2025.

What is the market cap of Dynatronics (DYNT)?

The market cap of Dynatronics (DYNT) is approximately 1.0M.

What is the primary business of Dynatronics Corp?

Dynatronics Corp designs, manufactures, and distributes advanced medical devices and rehabilitation equipment for clinical, sports, and therapeutic applications.

Which product categories does Dynatronics offer?

The company offers a wide range of products including treatment tables, rehabilitation equipment, and over 8,000 medical supplies used in physical therapy, chiropractic, and sports medicine.

How does Dynatronics ensure customer support?

Dynatronics is known for its experienced sales force and robust distribution network. The company provides comprehensive field support, including equipment setup and in-service training, to ensure optimal use of its products.

What distinguishes Dynatronics in the healthcare equipment industry?

Its longstanding reputation, advanced technological products, and unmatched clinical support differentiate Dynatronics, making it a trusted name among healthcare professionals.

Who are the typical customers of Dynatronics?

The company serves a broad range of customers including orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals.

How does Dynatronics maintain its quality standards?

Quality is maintained through rigorous manufacturing processes, competitive pricing, and thorough user training programs, all supported by a dedicated field support team.

In which market segments does Dynatronics operate?

Dynatronics operates in clinical and rehabilitative healthcare segments, covering acute care, physical therapy, athletic training, recreational medicine, and chiropractic services.

How does Dynatronics ensure the efficiency of its distribution network?

The company leverages a strong network of experienced sales representatives and active distributors, ensuring immediate service and support across the country.
Dynatronics Corp

OTC:DYNT

DYNT Rankings

DYNT Stock Data

1.01M
4.08M
42.15%
0.3%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SALT LAKE CITY